Key result
Primary aldosteronism had a prevalence of 0.93% in an unselected cohort of patients with type 2 diabetes, and plasma aldosterone was not strongly associated with diabetic complications.
Why the study?
What is the prevalence of primary aldosteronism in an unselected cohort of patients with type 2 diabetes?
Population
578 consecutively screened patients with type 2 diabetes from six outpatient clinics
Design
Cross-sectional
Authors
Loading...
Low PA prevalence in unselected T2D does not support routine screening; leaves open targeted evaluation in resistant hypertension.
Cross-Sectional (n=578)
Yes
What is the prevalence of primary aldosteronism in an unselected cohort of patients with type 2 diabetes?
The prevalence of primary aldosteronism in an unselected cohort of patients with type 2 diabetes is relatively low (0.93%), and plasma aldosterone is not strongly associated with diabetic complications.
Tancredi et al. (2017) conducted a cross-sectional in Type 2 diabetes (n=578). Primary aldosteronism had a prevalence of 0.93% in an unselected cohort of patients with type 2 diabetes, and plasma aldosterone was not strongly associated with diabetic complications.